These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 44198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of nicergoline on cerebral blood flow (author's transl)].
    Iliff LD, Du Boulay GH, Marshall J, Ross Russell RW, Symon L.
    Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
    [Abstract] [Full Text] [Related]

  • 3. [Hemodynamic effects of nicergolin in man at rest and during exertion (author's transl)].
    Boismare F, Lefrançois J.
    Arzneimittelforschung; 1979; 29(8a):1261-6. PubMed ID: 540069
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Some haemodynamic effects of nicergoline, a new alpha-blocking agent, in the closed-chest anaesthetized dog as compared with nitroprusside and nitroglycerin.
    Moore ND, Cazor JL, Leclerc JL, Saligaut C, Boismare F.
    Arzneimittelforschung; 1981; 31(10):1693-8. PubMed ID: 6797441
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM, Villa Badó J, Villalobos J, Iriarte JL, Ordeix R.
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative activity in the unanesthetized rabbit, of nicergoline and papaverine adenylate and 5-pyridoxal phosphate on local cerebral blood flow].
    Beaughard M, Cosnier D, Labrid C.
    Therapie; 1978; 33(4):475-90. PubMed ID: 734627
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J.
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [Abstract] [Full Text] [Related]

  • 18. Effects of two alpha-adrenoceptor antagonists, nicergoline and phentolamine, on myocardial oxygen consumption in the dog.
    Lièvre M, Kofman J, Andrieu JL, Faucon G.
    J Cardiovasc Pharmacol; 1983; 5(5):856-60. PubMed ID: 6195476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
    Boismare F, Moore N, Decourt S, Paux G, Saligaut C, Chretien P.
    Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.